Lifebit
Private Company
Total funding raised: $17M
Overview
Lifebit has established itself as a leading provider of secure, federated data analysis platforms for the global genomics and precision medicine ecosystem. Founded in 2017, its technology allows researchers to run analyses on distributed, sensitive datasets (e.g., patient genomic data) where the data remains in its secure origin, addressing critical privacy, logistical, and scalability challenges. The company's platform is trusted by major national health initiatives and pharmaceutical partners, positioning it at the forefront of enabling large-scale, collaborative biomedical discovery.
Technology Platform
Lifebit Platform: A federated, cloud-based Trusted Research Environment (TRE) that enables secure analysis of distributed genomic and clinical data without moving the data. Features include zero data movement, instant federation and harmonization, built-in compliance, and scalable AI/ML tools.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Lifebit competes in the genomic data analysis and Trusted Research Environment market against large cloud providers (AWS, Google, Microsoft) offering broad-based genomic services and specialized bioinformatics software companies. Its key differentiator is its foundational 'zero data movement' federated architecture, which is uniquely suited for highly sensitive, regulated data collaborations where data sovereignty is paramount.